TheraRadar
← Back
Data updated: Jun 28, 2026

SHERTECH LABS LLC

Generics
Pharmaceuticals

SHERTECH LABS LLC is a generic drug manufacturer with 2 FDA-approved products.

2014
Since
2
Drugs
-
Trials
0
New Drugs (2yr)

SHERTECH LABS LLC's Key Drugs

SHERTECH LABS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

SHERTECH LABS LLC's Recent FDA Approvals

New NDA/BLA approvals for SHERTECH LABS LLC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

SHERTECH LABS LLC's Therapeutic Areas

Disease areas where SHERTECH LABS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

SHERTECH LABS LLC Pipeline Snapshot

Active clinical trials for SHERTECH LABS LLC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling